COVALENT MODIFICATION OF DNA BY ANTINEOPLASTIC AGENTS

被引:0
|
作者
HEMMINKI, K
LUDLUM, DB
机构
[1] UNION UNIV ALBANY MED COLL,DEPT MED,ALBANY,NY 12208
[2] INST OCCUPAT HLTH,HAARTMANINKATU 1,SF-00290 HELSINKI 29,FINLAND
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1021 / 1028
页数:8
相关论文
共 50 条
  • [41] Novel antineoplastic agents.
    Bukowski R.M.
    Current Oncology Reports, 2000, 2 (1) : 9 - 10
  • [42] Thrombotic microangiopathies and antineoplastic agents
    Grange, Steven
    Coppo, Paul
    NEPHROLOGIE & THERAPEUTIQUE, 2017, 13 : S109 - S113
  • [43] Vascular toxicity of antineoplastic agents
    Shahab, N
    Haider, S
    Doll, DC
    SEMINARS IN ONCOLOGY, 2006, 33 (01) : 121 - 138
  • [44] PULMONARY TOXICITY OF ANTINEOPLASTIC AGENTS
    GREEN, MR
    WESTERN JOURNAL OF MEDICINE, 1977, 127 (04): : 292 - 298
  • [45] Musculoskeletal Effects of Antineoplastic Agents
    Sutton, Karen
    Sanft, Tara B.
    Knobf, Tish M.
    Ibe, Izuchukwu K.
    JOURNAL OF THE AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS, 2019, 27 (22) : 834 - 839
  • [46] DISPOSITION OF ANTINEOPLASTIC AGENTS IN INFANTS
    MCLEOD, HL
    RELLING, MV
    CROM, WR
    RODMAN, JR
    MADDEN, T
    GROOM, S
    SILVERSTEIN, K
    RIVERA, G
    EVANS, WE
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1991, 49 (02) : 161 - 161
  • [47] PRESCREENS FOR NOVEL ANTINEOPLASTIC AGENTS
    GREENSTEIN, M
    MAIESE, WM
    WHITE, RJ
    DEVELOPMENTS IN INDUSTRIAL MICROBIOLOGY, 1984, 25 : 267 - 275
  • [48] Antineoplastic agents and thrombotic microangiopathy
    Garcia, Gwenalyn
    Atallah, Jean Paul
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2017, 23 (02) : 135 - 142
  • [49] ANTINEOPLASTIC AGENTS AS A CAUSE OF FEVER
    PRINCE, RA
    KLAINER, AS
    DRUG INTELLIGENCE & CLINICAL PHARMACY, 1975, 9 (03): : 126 - 128
  • [50] RENAL TOXICITY OF ANTINEOPLASTIC AGENTS
    BORCH, RF
    MONTINE, TJ
    TOXICOLOGY LETTERS, 1990, 53 (1-2) : 93 - 96